Clinical Trial Update: Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of generic tazarotene cream 0.05% for plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Tazarotene Cream 0.05% (tazarotene)

Snippet

Sponsor: G & W Laboratories Inc. | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED